Related Experiment Video
Updated: Sep 19, 2025

Noninvasive, High-throughput Determination of Sleep Duration in Rodents
Published on: April 18, 2018
Is Objective Short Sleep a Proxy for Frequent Insomnia?
Hannah Scott1, Janet M Y Cheung2, Alexandria Muench3
1Adelaide Institute for Sleep Health: A Flinders Centre of Research Excellence, College of Medicine and Public Health, Flinders University, Adelaide, Australia.
Abstract:
This study investigated the relationship between insomnia frequency and objective short sleep, a phenotype of insomnia. The hypothesis is that individuals with objective short sleep simply have more nights of insomnia per week. Data from a randomised controlled trial of Cognitive Behavioural Therapy for Insomnia combined with zolpidem and/or additional maintenance sessions were analysed. Insomnia frequency was derived from pre-treatment sleep diaries, using two definitions: nights with self-reported sleep latency (SL) or wake after sleep onset (WASO) > 30 min, and nights with self-reported sleep duration < 6 h. Objective short sleep was assessed via PSG sleep study, using < 6 h as the threshold. Results showed that objective short sleep was associated with more frequent insomnia when defined as nights with sleep duration < 6 h (8.1 ± 4.2 vs. 5.9 ± 3.7 nights/fortnight for short sleepers vs. normal sleepers, respectively), but not for nights with SL or WASO > 30 min. While insomnia frequency may partially explain objective short sleep, other factors likely influence this phenotype. Further studies are needed to explore the mechanisms underlying objective short sleep insomnia.
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

